跳至主要内容
临床试验/NCT04548830
NCT04548830已完成2 期

Safety of Transbronchial Cryobiopsy in a Cancer Population

Memorial Sloan Kettering Cancer Center1 个研究点 分布在 1 个国家目标入组 115 人开始时间: 2020年9月8日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
入组人数
115
试验地点
1
主要终点
Post Cryobiopsy complications

研究概览

简要总结

The purpose of this study is to find out whether a biopsy technique called transbronchial cryobiopsy (TBCB) is a safe alternative to the standard biopsy procedure (transbronchial forceps biopsy; TBFB). The study researchers think that TBCB may provide better biopsy samples to help diagnose lung disease.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years of age or greater
  • Patients with known or suspected diagnosis of cancer and indeterminant pulmonary nodules or diffuse parenchymal lung disease with non-diagnostic clinical profiles for whom a lung biopsy is deemed useful for diagnosis.

排除标准

  • Patients with pulse oximetry less than 92% on oxygen delivery up to 2 L nasal cannula.
  • Uncorrectable coagulopathy defined as:
  • Platelet count <50,000 x 10^9/L or
  • prothrombin time international normalized ratio >1.5
  • Known pulmonary hypertension or echocardiographic pulmonary artery systolic pressure >50mmHg
  • A secure diagnosis based on clinical and high-resolution CT scan data.
  • Antiplatelet therapy that cannot be held for more than 5 days.
  • Any patient deemed unfit to undergo bronchoscopy by the proceduralist
  • Female patients with a positive pregnancy test within 30 days of the planned study procedure

研究组 & 干预措施

Transbronchial cryobiopsy

Experimental

All study participants will undergo transbronchial biopsies via our proposed standardized cryo-biopsy protocol in place of the traditional forceps transbronchial biopsy that is typically used at MSK.

干预措施: Transbronchial cryobiopsy (Procedure)

结局指标

主要结局

Post Cryobiopsy complications

时间窗: 2 years

will be graded according to Common Terminology Criteria for Adverse Events version 5 (CTCAE v5)

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验